US, Blue Bell (ICON)
Onsite
Medical Affairs
Brazil, Sao Paulo
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Poland, Warsaw; Spain, Madrid; Slovakia, Bratislava; Bulgaria, Sofia; Latvia, Riga; Lithuania, Vilnius; Czech Republic, Prague; South Africa, Johannesburg
Onsite
Clinical Development
US, Lenexa KCI (PRA)
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Netherlands, Utrecht, Zen
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Netherlands, Utrecht, Zen
Onsite
Clinical Development
Netherlands, Utrecht, Zen
Onsite
Clinical Development
US, Blue Bell (PRA)
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
US, Blue Bell (ICON); Miami, FL
Onsite
Clinical Development
Italy, Milan
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
Colombia, Bogota; Brazil, Sao Paulo; Mexico, Mexico City
Onsite
Clinical Development
Canada, Montreal; Canada, Burlington
Onsite
Clinical Development
US, Lenexa KCI (PRA)
Onsite
Clinical Development
Mexico, Mexico City; Colombia, Bogota
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Poland, Warsaw; Romania, Bucharest; Spain, Madrid; Czech Republic, Prague; Hungary, Budapest; Bulgaria, Sofia
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
India, Chennai
Onsite
Clinical Development
US, Blue Bell (ICON); Houston, TX
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Texas
Onsite
Clinical Development
Canada
Onsite
Clinical Development
China, Beijing
Onsite
Clinical Development
Georgia, Tbilisi
Onsite
Clinical Development
China, Beijing; China, Shanghai; China, Chengdu
Onsite
Clinical Development
Sweden, Lund
Onsite
Clinical Development
South Africa, Johannesburg
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
India, Bangalore; India, Chennai
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Hungary, Budapest
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
China, Wuhan
Onsite
Clinical Development
China, Guangzhou
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
Kansas City, MO; US, Lawrence, KS
Onsite
Clinical Development
Chicago, IL; Indianapolis, IN
Onsite
Clinical Development
India, Bangalore; India, Trivandrum; India, Chennai
Onsite
Clinical Development
Kenya
Onsite
Clinical Development
Romania, Bucharest; Georgia, Tbilisi
Onsite
Clinical Development
US, Lenexa KCI (PRA)
Onsite
Clinical Development
Ireland, Dublin; Italy, Rome; Israel, Tel Aviv; Sweden, Lund; Hungary, Budapest; Croatia, Zagreb; Denmark, Copenhagen; Czech Republic, Prague; Turkey, Istanbul; France, Paris; Finland, Helsinki; Spain, Madrid; Slovakia, Bratislava; Bulgaria, Sofia; Serbia, Belgrade; Austria, Vienna; Romania, Bucharest; Greece, Athens; Portugal, Lisbon; Estonia, Tallinn; Poland, Warsaw; Germany, Mannheim; South Africa, Johannesburg; Georgia, Tbilisi; Regional Norway; UK, Reading; Latvia, Riga; Lithuania, Vilnius; Kenya
Onsite
Clinical Development
Spain, Madrid; Spain, Barcelona
Onsite
Clinical Development
Italy, Milan
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Singapore, Singapore
Onsite
Clinical Development
Japan, Tokyo
Onsite
Clinical Development
Spain, Barcelona; Hungary, Budapest; UK, Reading; Bulgaria, Sofia; Portugal, Lisbon; Greece, Athens; Czech Republic, Prague; Poland, Warsaw
Onsite
Clinical Development
China, Beijing; China, Tianjin; China, Changsha; China, Zhengzhou; China, Shenyang; China, Hangzhou; China, Dalian (PRA); China, Xi'an; China, Wuhan; China, Nanjing; China, Shanghai; China, Chengdu; China, Guangzhou
Onsite
Clinical Development
China, Beijing; China, Tianjin; China, Changsha; China, Zhengzhou; China, Shenyang; China, Hangzhou; China, Dalian (PRA); China, Xi'an; China, Wuhan; China, Nanjing; China, Shanghai; China, Chengdu; China, Guangzhou
Onsite
Clinical Development
US, Blue Bell (ICON); Virginia; Texas; Kansas; Tennessee; Florida; UK, Reading; Indiana; Georgia
Onsite
Clinical Development
Serbia, Belgrade
Onsite
Clinical Development
Turkey, Istanbul
Onsite
Clinical Development
Thailand, Bangkok
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Ukraine, Kyiv IKBP
Onsite
Clinical Development
US, Blue Bell (ICON); Canada, Burlington
Onsite
Clinical Development
Belgium, Mechelen; Netherlands, Assen; France, Paris; Spain, Madrid; Switzerland, Basel; UK, Reading; Germany, Frankfurt; Poland, Warsaw
Onsite
Clinical Development
US, Blue Bell (ICON); Regional Canada (PRA) (Do Not Use)
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Ireland, Dublin
Onsite
Clinical Development
Australia, Sydney
Onsite
Clinical Development
US, Blue Bell (ICON); US, Salt Lake City (PRA); US, Portland, OR; US, Illinois (Symphony), IL
Onsite
Clinical Development
Nebraska
Onsite
Clinical Development
South Carolina
Onsite
Clinical Development
Philippines, Manila
Onsite
Clinical Development
Atlanta,GA; Pennsylvania; Texas; Los Angeles, CA; Florida
Onsite
Clinical Development
Mexico Mexico City
Onsite
Clinical Development
Texas
Onsite
Clinical Development
Canada, Montreal; Toronto; Quebec City; New Brunswick; Quebec; British Columbia; Canada, Burlington; Vancouver
Onsite
Clinical Development
Portugal, Lisbon
Onsite
Clinical Development
United States of America; US, Nashville, TN; US, Lenexa KCI (PRA); US, Hickory, NC; US, Raleigh, NC; US, Mt. Pleasant, SC; US, Bristol, TN; US, Cary, NC; US, Salisbury, NC; US, Charlotte, NC; US, Rocky Mount, NC; US, Raleigh, NC, 27609; US, Long Beach, CA; US, New York, NY, Rochester; US, Knoxville, TN; US, Sherman Oaks, CA; US, San Antonio, TX 78232; US, Lawrence, KS; US, Portland, OR; US, Cambridge, MA; US, Downers Grove, IL; US, Piedmont, NC; US, McFarland, IA; US, Houston, TX; US, Lexington, KY; US, New York, NY, Whitesboro; US, Farmingdale, NY; US, Wilmington, NC
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
Portugal, Lisbon; Spain, Madrid; Poland, Warsaw; UK, Reading; Ireland, Dublin; South Africa, Johannesburg
Onsite
Clinical Development
Bulgaria, Sofia; Spain, Madrid; Czech Republic, Prague; Poland, Warsaw; Hungary, Budapest
Onsite
Clinical Development
Germany, Frankfurt; Netherlands, Assen; France, Paris; Switzerland, Zurich; Spain, Barcelona; Regional Great Britain (Northern Ireland); UK, Reading; Portugal, Lisbon; Italy, Florence
Onsite
Clinical Development
Bulgaria, Sofia; Serbia, Belgrade
Onsite
Clinical Development
Poland, Warsaw; Spain, Madrid; Czech Republic, Prague; Hungary, Budapest; Spain, Barcelona; Bulgaria, Sofia
Onsite
Clinical Development
Netherlands, Utrecht, Zen
Onsite
Clinical Development
Netherlands, Utrecht, Zen
Onsite
Clinical Development
China, Beijing
Onsite
Clinical Development
US, Raleigh, NC
Onsite
Clinical Development
Thailand, Bangkok
Onsite
Clinical Development
Israel, Tel Aviv
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
Malaysia, Kuala Lumpur
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
Poland, Warsaw; Poland, Gdansk
Onsite
Clinical Development
Spain, Barcelona
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
California; Los Angeles, CA; San Diego, CA
Onsite
Clinical Development
Canada, Burlington; Canada, Montreal
Onsite
Clinical Development
China, Guangzhou; China, Wuhan
Onsite
Clinical Development
China, Nanjing
Onsite
Clinical Development
Hungary, Budapest; Spain, Madrid
Onsite
Clinical Development
United States of America; Michigan; Texas; Kansas; Oklahoma; Kentucky; Ohio; Minnesota; Louisiana; Missouri; Iowa
Onsite
Clinical Development
New York; South Carolina; Pennsylvania; Florida; New Jersey; Massachusetts; North Carolina
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
United States of America; US, Raleigh, NC; Houston, TX
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Canada, Montreal
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
Netherlands, Assen
Onsite
Clinical Development
Germany, Frankfurt; Netherlands, Assen; Spain, Barcelona; UK, Reading
Onsite
Clinical Development
US, Lenexa KCI (PRA)
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
India, Bangalore
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Italy, Milan
Onsite
Clinical Development
China, Beijing; Taiwan, Taipei
Onsite
Clinical Development
Czech Republic, Prague
Onsite
Clinical Development
Texas; Nebraska; Illinois; Missouri
Onsite
Clinical Development
California; US, Washington; Arizona; US, Colorado
Onsite
Clinical Development
Chile, Santiago
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Ireland, Dublin; Bulgaria, Sofia
Onsite
Clinical Development
US, Lenexa KCIB (PRA)
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
US, Blue Bell (PRA)
Onsite
Clinical Development
China, Beijing
Onsite
Clinical Development
Regional Great Britain (Northern Ireland)
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
Bulgaria, Sofia; Poland, Warsaw
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
US, Blue Bell (ICON); Canada, Burlington
Onsite
Clinical Development
Regional Great Britain (Northern Ireland); Poland, Warsaw; Bulgaria, Sofia
Onsite
Clinical Development
Denmark, Copenhagen
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Poland, Warsaw; Poland, Gdansk
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
Romania, Bucharest
Onsite
Clinical Development
Canada, Montreal; Canada, Burlington
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
Australia, Sydney
Onsite
Clinical Development
Australia, Sydney; Australia, Brisbane; Australia, Melbourne
Onsite
Clinical Development
Australia, Sydney
Onsite
Clinical Development
India, Chennai
Onsite
Clinical Development
China, Guangzhou
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
US, Lenexa KCI (PRA)
Onsite
Clinical Development
Netherlands, Groningen GRQM
Onsite
Clinical Development
Italy, Milan
Onsite
Clinical Development
China, Guangzhou
Onsite
Clinical Development
Mexico, Mexico City; Colombia, Bogota
Onsite
Clinical Development
Regional Guatemala (PRA)
Onsite
Clinical Development
India, Chennai; India, Bangalore
Onsite
Clinical Development
Ireland, Dublin; France, Paris; Finland, Helsinki; Spain, Madrid; Slovakia, Bratislava; Serbia, Belgrade; Bulgaria, Sofia; Austria, Vienna; Romania, Bucharest; Portugal, Lisbon; Estonia, Tallinn; Italy, Milan; Poland, Warsaw; South Africa, Johannesburg; Hungary, Budapest; Denmark, Copenhagen; UK, Reading; Latvia, Riga; Lithuania, Vilnius; Germany, Frankfurt
Onsite
Clinical Development
Ireland, Dublin; Spain, Barcelona; Hungary, Budapest; UK, Reading; UK, Swansea; Portugal, Lisbon; Poland, Warsaw; South Africa, Johannesburg
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Project Management
Spain Madrid
Onsite
Project Management
US, Blue Bell (ICON)
Onsite
Project Management
Mexico Mexico City
Onsite
Project Management
India, Chennai
Onsite
Project Management
Japan Tokyo
Onsite
Project Management
UK Reading
Onsite
Project Management
Canada, Burlington
Onsite
Project Management
Ireland Dublin
Onsite
Project Management
US, Blue Bell (ICON)
Onsite
Project Management
US, Blue Bell (ICON)
Onsite
Project Management
US, Blue Bell (ICON)
Onsite
Project Management
US, Blue Bell (ICON)
Onsite
Project Management
Spain Barcelona
Onsite
Project Management
US, Blue Bell (PRA)
Onsite
Project Management
Mexico, Mexico City
Onsite
Project Management
China Beijing
Onsite
Project Management
US, Blue Bell (ICON)
Onsite
Project Management
Ireland, Dublin
Onsite
Project Management
US Blue Bell ICON
Onsite
Project Management
US Blue Bell ICON
Onsite
Project Management
United States of America
Onsite
Project Management
US, Blue Bell (ICON)
Onsite
Project Management
US, Blue Bell (PRA)
Onsite
Project Management
Canada, Burlington
Onsite
Project Management
United States of America
Onsite
Project Management
US Blue Bell PRA
Onsite
Project Management
Poland, Warsaw
Onsite
Project Management
South Africa Johannesburg
Onsite
Medical Regulatory Affairs
Japan Tokyo
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
US Blue Bell ICON
Onsite
Medical Regulatory Affairs
Romania, Bucharest
Onsite
Medical Regulatory Affairs
India Bangalore
Onsite
Medical Regulatory Affairs
UK, Reading
Onsite
Medical Regulatory Affairs
Regional United States PRA
Onsite
Medical Regulatory Affairs
Ireland, Dublin
Onsite
Finance
US, Blue Bell (ICON)
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
US, Raleigh, NC
Onsite
Medical Regulatory Affairs
Poland Warsaw
Onsite
Medical Regulatory Affairs
China Shanghai
Onsite
Medical Regulatory Affairs
US, Blue Bell (ICON)
Onsite
Finance
Brazil, Sao Paulo
Onsite
Finance
Australia Sydney
Onsite
Business Development
Ireland, Dublin
Onsite
Finance
Poland, Warsaw
Onsite
Business Development
Ireland, Dublin
Onsite
Finance
US, Wilmington, NC
Onsite
Business Development
Germany, Frankfurt
Onsite
Business Development
Ireland, Dublin
Onsite
Finance
US, Lenexa KCIB (PRA)
Onsite
Quality Assurance Methods
US, Farmingdale, NY
Onsite
Facilities & Administratives Services
Philippines, Manila
Onsite
Facilities & Administratives Services
US, Blue Bell (ICON)
Onsite
IT
US, New York, NY, Whitesboro
Onsite
Drug Development and Preclinical Studies
India Trivandrum
Onsite
IT
Netherlands, Assen
Onsite
Drug Development and Preclinical Studies
Brazil, Sao Paulo
Onsite
Medical Regulatory Affairs
China, Beijing
Onsite
Legal
Ireland, Dublin
Onsite
IT
US, Blue Bell (ICON)
Onsite
Business Development
United States of America
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Finance
Brazil, Sao Paulo
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
Czech Republic, Prague
Onsite
Clinical Development
Bulgaria, Sofia; Poland, Warsaw
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
China, Beijing; China, Shanghai
Onsite
Clinical Development
Spain, Barcelona; Spain, Madrid
Onsite
Clinical Development
Bulgaria, Sofia; Poland, Warsaw; Georgia, Tbilisi
Onsite
Clinical Development
Spain, Barcelona; Spain, Madrid
Onsite
Clinical Development
US, Hickory, NC
Onsite
Clinical Development
US, Blue Bell (ICON); Orlando, FL; Miami, FL; Florida; Tampa, FL
Onsite
Clinical Development
Regional United States (PRA)
Onsite
Clinical Development
Brazil, Sao Paulo; Argentina, Buenos Aires; Mexico, Mexico City
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
US, Downers Grove, IL; US, Lisle, Illinois
Onsite
Clinical Development
US, Raleigh, NC, 27609
Onsite
Clinical Development
US, Downers Grove, IL; US, Lombard, Illinois
Onsite
Clinical Development
Israel, Tel Aviv
Onsite
Clinical Development
Israel, Tel Aviv
Onsite
Clinical Development
Greece, Athens
Onsite
Clinical Development
UK, Northhamptonshire (Accellacare)
Onsite
Clinical Development
China, Xi'an
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
US, Raleigh, NC
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
California
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
UK, Livingston
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
Ireland, Dublin
Onsite
Clinical Development
Bulgaria, Sofia; South Africa, Johannesburg
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
Kenya
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
India, Bangalore
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Project Management
Australia Sydney
Onsite
Business Development
Korea, Seoul
Onsite
Clinical Development
Kansas City, MO; Pennsylvania; Texas; Los Angeles, CA; Chicago, IL; Georgia
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
Turkey, Ankara; Turkey Adana; Turkey Izmir; Turkey, Istanbul
Onsite
Clinical Development
China, Hangzhou
Onsite
Clinical Development
UK Reading
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
US, San Antonio, TX, IDS
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
US, Lenexa KCIB (PRA)
Onsite
Clinical Development
UK Reading
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
Ireland, Dublin
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Romania, Bucharest
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
US Blue Bell ICON
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Sweden Lund
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
UK Reading
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
UK, Swansea; Romania, Bucharest
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Belgium, Mechelen
Onsite
Clinical Development
Bulgaria, Sofia; Spain, Barcelona; UK, Reading; Romania, Bucharest; Portugal, Lisbon; Poland, Warsaw; Estonia, Tallinn; Ireland, Dublin
Onsite
Clinical Development
Montreal
Onsite
Clinical Development
Romania, Bucharest
Onsite
Clinical Development
US, Downers Grove, IL; US, Houston, TX
Onsite
Clinical Development
US, Houston, TX; Austin, TX; Dallas, TX
Onsite
Clinical Development
Poland, Warsaw; Romania, Bucharest; Czech Republic, Prague; Hungary, Budapest; Bulgaria, Sofia
Onsite
Clinical Development
Colombia, Bogota
Onsite
Clinical Development
Austria, Vienna RPS
Onsite
Clinical Development
US, Blue Bell (PRA); Texas; Missouri; Wisconsin; Chicago, IL
Onsite
Clinical Development
US, Raleigh, NC
Onsite
Clinical Development
US, Raleigh, NC
Onsite
Clinical Development
US, Raleigh, NC
Onsite
Clinical Development
California
Onsite
Clinical Development
UK, Reading; Germany, Frankfurt; Spain, Madrid; Greece, Athens
Onsite
Clinical Development
Netherlands, Groningen GRQP
Onsite
Clinical Development
Hungary, Budapest; Romania, Bucharest; Poland, Warsaw; Bulgaria, Sofia
Onsite
Clinical Development
Hong Kong, Hong Kong
Onsite
Clinical Development
Czech Republic, Prague; Romania, Bucharest; Hungary, Budapest; Bulgaria, Sofia
Onsite
Clinical Development
Spain, Madrid; Romania, Bucharest; Greece, Athens; Hungary, Budapest; Bulgaria, Sofia
Onsite
Clinical Development
UK, Reading; Hungary, Budapest; Bulgaria, Sofia; Romania, Bucharest; Germany, Frankfurt; Kenya; Poland, Gdansk; Ireland, Dublin; South Africa, Johannesburg
Onsite
Clinical Development
Mexico, Mexico City; Regional Argentina (PRA) (DO NOT USE)
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
Italy, Milan
Onsite
Clinical Development
Canada, Burlington; Vancouver; Alberta
Onsite
Clinical Development
Canada, Burlington
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Utah
Onsite
Clinical Development
UK, Reading; Spain, Barcelona; Romania, Bucharest; Germany, Frankfurt; Portugal, Lisbon; Greece, Athens; France, Lyon; Poland, Warsaw; South Africa, Johannesburg
Onsite
Clinical Development
China, Chengdu
Onsite
Clinical Development
India, Bangalore
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
New York, NY; South Carolina; Virginia; Pennsylvania; Maryland; Florida; New York; Massachusetts; New Hampshire
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
California
Onsite
Clinical Development
US, Blue Bell (ICON); Mexico, Mexico City; United States of America
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
Peru, Lima; Chile, Santiago
Onsite
Clinical Development
Miami, FL; Florida
Onsite
Clinical Development
China, Guangzhou
Onsite
Clinical Development
Bulgaria, Sofia; Romania, Bucharest; Poland, Warsaw; Hungary, Budapest
Onsite
Clinical Development
Texas; North Carolina; Florida; Chicago, IL; Georgia; Ohio
Onsite
Clinical Development
Spain, Madrid; Spain, Barcelona; US, Blue Bell (ICON); UK, Reading; UK, Swansea; Poland, Warsaw; Ireland, Dublin
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
Australia, Sydney; Australia, Melbourne
Onsite
Clinical Development
Malaysia, Kuala Lumpur
Onsite
Clinical Development
Philippines, Manila
Onsite
Clinical Development
Japan, Tokyo; Japan, Osaka
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Spain, Madrid
Onsite
Clinical Development
US, Blue Bell (ICON); United States of America
Onsite
Clinical Development
Regional Great Britain (Northern Ireland)
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
China, Beijing; China, Shanghai
Onsite
Clinical Development
China, Beijing
Onsite
Clinical Development
Basking Ridge, NJ; Warren, NJ
Onsite
Clinical Development
Hong Kong, Hong Kong
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
Regional United States (PRA)
Onsite
Clinical Development
Turkey, Ankara
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Switzerland, Zurich; Switzerland, Teichgaesslein Basel
Onsite
Clinical Development
Netherlands, Assen
Onsite
Clinical Development
Turkey, Istanbul
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Belgium, Mechelen
Onsite
Clinical Development
Turkey, Istanbul
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
Poland, Warsaw; Romania, Bucharest; Hungary, Budapest; Spain, Barcelona; Ireland, Dublin
Onsite
Clinical Development
US, San Antonio, TX, IDS
Onsite
Clinical Development
Canada, Montreal
Onsite
Clinical Development
Hungary, Budapest
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
Poland, Warsaw; Romania, Bucharest; Kenya; Hungary, Budapest; Bulgaria, Sofia; South Africa, Johannesburg
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
Bulgaria Sofia
Onsite
Project Management
US, Portland, OR
Onsite
Clinical Development
UK Reading
Onsite
Project Management
Argentina, Buenos Aires
Onsite
Medical Regulatory Affairs
US, Portland, OR
Onsite
Clinical Development
UK Reading
Onsite
Business Development
US, Portland, OR
Onsite
Clinical Development
US, Lenexa KCIB (PRA)
Onsite
Facilities & Administratives Services
UK, Reading; Lithuania, Vilnius; Poland, Warsaw; Spain, Barcelona; Bulgaria, Sofia
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Drug Development and Preclinical Studies
Taiwan, Taipei
Onsite
Clinical Development
US Raleigh NC
Onsite
Human Resources
China, Beijing
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
Texas; Missouri; Wisconsin; Oklahoma; Chicago, IL
Onsite
Clinical Development
US, Lenexa KCI (PRA)
Onsite
Clinical Development
Belgium, Mechelen
Onsite
Clinical Development
Canada
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Malaysia, Kuala Lumpur
Onsite
Clinical Development
UK, Swansea; Ireland, Dublin
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
Australia, Sydney; Australia, Perth; Australia, Brisbane; Australia, Adelaide; Australia, Melbourne
Onsite
Clinical Development
Turkey, Istanbul
Onsite
Clinical Development
Canada Burlington
Onsite
Project Management
Poland, Warsaw
Onsite
Project Management
Poland Warsaw
Onsite
Project Management
Japan Tokyo
Onsite
Project Management
Spain Barcelona
Onsite
Project Management
UK, Reading
Onsite
Project Management
US Blue Bell ICON
Onsite
Project Management
US Blue Bell ICON
Onsite
Project Management
Bulgaria, Sofia
Onsite
Project Management
US Blue Bell PRA
Onsite
Project Management
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Philippines, Manila
Onsite
Medical Regulatory Affairs
Brazil, Sao Paulo
Onsite
Medical Regulatory Affairs
Brazil, Sao Paulo
Onsite
Medical Regulatory Affairs
Poland Warsaw
Onsite
Medical Regulatory Affairs
India, Bangalore
Onsite
Medical Regulatory Affairs
Mexico Mexico City
Onsite
Medical Regulatory Affairs
Ireland, Dublin
Onsite
Finance
Argentina, Buenos Aires
Onsite
Medical Regulatory Affairs
Brazil, Sao Paulo
Onsite
Medical Regulatory Affairs
Turkey, Ankara
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
US, Blue Bell (ICON)
Onsite
Medical Regulatory Affairs
India, Chennai
Onsite
Finance
India, Chennai
Onsite
Finance
US Blue Bell ICON
Onsite
Finance
Portugal, Lisbon
Onsite
Finance
Spain Barcelona
Onsite
Finance
Spain Madrid
Onsite
Finance
China, Beijing
Onsite
Business Development
US, Blue Bell (ICON)
Onsite
Business Development
US, Blue Bell (ICON)
Onsite
Business Development
Ireland Dublin
Onsite
Business Development
UK Reading
Onsite
Business Development
Germany, Frankfurt
Onsite
Medical Affairs
Poland, Warsaw
Onsite
Medical Affairs
Boston MA
Onsite
Drug Development and Preclinical Studies
Regional United States (PRA)
Onsite
Quality Assurance Methods
United States of America
Onsite
Quality Assurance Methods
US, Blue Bell (ICON)
Onsite
Medical Affairs
Ireland, Dublin
Onsite
Business Development
Mexico, Mexico City
Onsite
Facilities & Administratives Services
US, Lenexa KCIB (PRA)
Onsite
Drug Development and Preclinical Studies
UK, Reading
Onsite
Business Development
US, Portland, OR
Onsite
Quality Assurance Methods
Poland Warsaw
Onsite
Medical Affairs
US Blue Bell ICON
Onsite
Human Resources
Germany, Frankfurt
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Human Resources
Spain, Madrid
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Project Management
China, Shanghai
Onsite
Project Management
Mexico, Mexico City
Onsite
Project Management
Brazil, Sao Paulo
Onsite
Medical Regulatory Affairs
India Bangalore
Onsite
IT
US, New York, NY, Whitesboro
Onsite
Drug Development and Preclinical Studies
US, Lenexa KCI (PRA)
Onsite
Facilities & Administratives Services
United States of America
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Colombia, Bogota
Onsite
Medical Regulatory Affairs
Ireland, Dublin
Onsite
Finance
US, Lenexa KCIB (PRA)
Onsite
Drug Development and Preclinical Studies
US, Blue Bell (ICON)
Onsite
Drug Development and Preclinical Studies
India, Chennai; India, Bangalore
Onsite
Clinical Development
India, Chennai
Onsite
Finance
Argentina, Buenos Aires
Onsite
Clinical Development
US, Piedmont, NC; US, Statesville, North Carolina
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
US, Portland, OR
Onsite
Clinical Development
US, Long Beach, CA
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Spain, Madrid; Spain, Barcelona; Hungary, Budapest; UK, Reading; Bulgaria, Sofia; Romania, Bucharest; Portugal, Lisbon; Czech Republic, Prague
Onsite
Clinical Development
Lithuania, Vilnius; Poland, Warsaw; Bulgaria, Sofia
Onsite
Clinical Development
Japan Tokyo
Onsite
Medical Regulatory Affairs
Korea, Seoul
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
Washington DC; Virginia
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Romania, Bucharest
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Hungary, Budapest BUD2
Onsite
Medical Regulatory Affairs
Ireland, Dublin
Onsite
Finance
Georgia Tbilisi
Onsite
Quality Assurance Methods
UK Reading
Onsite
Marketing & Media
India, Bangalore; India, Chennai
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Japan Tokyo
Onsite
Medical Regulatory Affairs
Ireland Dublin
Onsite
Business Development
Detroit, MI
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
Hungary, Budapest
Onsite
Clinical Development
Israel, Tel Aviv
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Kenya
Onsite
Clinical Development
Spain, Madrid
Onsite
Clinical Development
India, Bangalore; India, Chennai
Onsite
Clinical Development
Ireland, Dublin
Onsite
Clinical Development
Greece, Athens
Onsite
Clinical Development
US, Raleigh, NC
Onsite
Clinical Development
Regional Guatemala (PRA); Romania, Bucharest; Spain, Madrid; Poland, Warsaw; Bulgaria, Sofia
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
UK Reading
Onsite
Project Management
UK, Reading
Onsite
Project Management
US, Blue Bell (ICON)
Onsite
Project Management
Poland, Warsaw
Onsite
Clinical Development
UK, Reading; UK, Livingston; UK, Swansea
Onsite
Clinical Development
Poland, Warsaw; Bulgaria, Sofia; South Africa, Johannesburg
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
Poland, Warsaw; Poland, Gdansk
Onsite
Clinical Development
Germany Frankfurt
Onsite
Clinical Development
Japan, Tokyo; Japan, Osaka
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Chile, Santiago
Onsite
Clinical Development
Brazil Sao Paulo
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
India, Bangalore
Onsite
Clinical Development
Texas; Indianapolis, IN; Kansas City, MO; Dallas, TX
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
Hungary, Budapest; Romania, Bucharest; Spain, Madrid; Poland, Warsaw; Bulgaria, Sofia
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
US, Lenexa KCIB (PRA)
Onsite
Clinical Development
Quebec
Onsite
Clinical Development
India, Chennai
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Peru, Lima
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Bulgaria Sofia
Onsite
Medical Regulatory Affairs
Bulgaria, Sofia
Onsite
Medical Regulatory Affairs
Poland Gdansk
Onsite
Project Management
Romania Bucharest
Onsite
Finance
Ireland, Dublin
Onsite
Finance
Taiwan, Taipei
Onsite
Facilities & Administratives Services
UK, Reading
Onsite
Business Development
Australia, Sydney
Onsite
Business Development
US, Farmingdale, NY
Onsite
IT
Netherlands, Groningen GRQM
Onsite
Facilities & Administratives Services
US, Blue Bell (ICON)
Onsite
Business Development
US, San Antonio, TX 78232
Onsite
Facilities & Administratives Services
Poland, Warsaw
Onsite
Business Development
Mexico, Mexico City
Onsite
Finance
UK Reading
Onsite
Quality Assurance Methods
UK, Swansea
Onsite
Finance
UK, Reading
Onsite
Finance
UK Reading
Onsite
Quality Assurance Methods
Mexico, Mexico City
Onsite
Facilities & Administratives Services
Poland, Warsaw
Onsite
Finance
Toronto
Onsite
Business Development
Hungary, Budapest
Onsite
Finance
Ireland, Dublin
Onsite
IT
India, Bangalore; India, Trivandrum; India, Chennai
Onsite
Clinical Development
Netherlands, Groningen GRQM
Onsite
Clinical Development
Netherlands, Assen
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Philippines, Manila
Onsite
Medical Regulatory Affairs
Brazil, Sao Paulo
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Clinical Development
France, Paris
Onsite
Business Development
Brazil, Sao Paulo
Onsite
Human Resources
Ireland Dublin
Onsite
Finance
India Chennai
Onsite
Medical Regulatory Affairs
Colombia Bogota
Onsite
Project Management
Mexico Mexico City
Onsite
Quality Assurance Methods
Brazil, Sao Paulo; Argentina, Buenos Aires; Colombia, Bogota; Peru, Lima
Onsite
Clinical Development
India, Chennai
Onsite
Finance
Italy, Milan
Onsite
Clinical Development
Italy, Milan
Onsite
Clinical Development
Poland, Warsaw; Przemysl; Poznan; Poland, Gdansk; Lodz; Gliwice
Onsite
Clinical Development
Turkey, Istanbul; Turkey, Ankara
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
US, Lenexa KCI (PRA)
Onsite
Clinical Development
US, Blue Bell (ICON); Maryland
Onsite
Clinical Development
Poland, Warsaw; Poland, Gdansk
Onsite
Clinical Development
Los Angeles, CA; Seattle, WA; US, Portland, OR
Onsite
Clinical Development
US, San Antonio, TX, IDS
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Peru, Lima
Onsite
Clinical Development
Bulgaria, Sofia; Romania, Bucharest; Czech Republic, Prague; Hungary, Budapest
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Belgium, Mechelen
Onsite
Clinical Development
Netherlands, Assen
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
India, Chennai
Onsite
Clinical Development
Hungary Budapest
Onsite
Clinical Development
US, San Antonio, TX, IDS
Onsite
Clinical Development
Connecticut
Onsite
Clinical Development
Georgia; Florida; North Carolina
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Romania, Bucharest; Spain, Madrid; Bulgaria, Sofia; Portugal, Lisbon; Poland, Warsaw; South Africa, Johannesburg; Ireland, Dublin; Hungary, Budapest; UK, Reading; Latvia, Riga; Lithuania, Vilnius; Poland, Gdansk; Czech Republic, Prague
Onsite
Clinical Development
Poland, Warsaw; Spain, Madrid; Hungary, Budapest; Bulgaria, Sofia; Romania, Bucharest; Portugal, Lisbon; Czech Republic, Prague
Onsite
Clinical Development
US, Houston, TX
Onsite
Clinical Development
Bulgaria, Sofia
Onsite
Clinical Development
South Africa, Johannesburg; Spain, Madrid; Bulgaria, Sofia; Romania, Bucharest; Portugal, Lisbon; Estonia, Tallinn; Poland, Warsaw; Ireland, Dublin; Spain, Barcelona; Croatia, Zagreb; Lithuania, Vilnius; Czech Republic, Prague; Poland, Gdansk; Kenya
Onsite
Clinical Development
Japan, Tokyo
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
Turkey, Ankara
Onsite
Clinical Development
Portugal, Lisbon
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Clinical Development
Hong Kong, Hong Kong
Onsite
Clinical Development
Malaysia, Kuala Lumpur
Onsite
Clinical Development
Mumbai
Onsite
Clinical Development
Spain, Madrid; Spain, Barcelona
Onsite
Clinical Development
Turkey, Ankara
Onsite
Clinical Development
India, Bangalore; India, Trivandrum; India, Chennai
Onsite
Clinical Development
Belgium, Mechelen
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
Taiwan, Taipei; China, Dalian (PRA)
Onsite
Clinical Development
China, Beijing; China, Tianjin; China, Changsha; China, Zhengzhou; China, Shenyang; China, Hangzhou; China, Dalian (PRA); China, Xi'an; China, Wuhan; China, Nanjing; China, Shanghai; China, Chengdu; China, Guangzhou
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
Japan, Tokyo
Onsite
Clinical Development
US Blue Bell ICON
Onsite
Medical Regulatory Affairs
US, New York, NY, Whitesboro
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Miami, FL
Onsite
Clinical Development
Canada
Onsite
Clinical Development
Japan Osaka
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Romania, Bucharest; Kenya; Poland, Warsaw; Hungary, Budapest; Bulgaria, Sofia; South Africa, Johannesburg
Onsite
Clinical Development
Singapore, Singapore; Malaysia, Kuala Lumpur
Onsite
Clinical Development
Canada
Onsite
Clinical Development
Detroit, MI
Onsite
Clinical Development
China Beijing
Onsite
Clinical Development
India Bangalore
Onsite
Clinical Development
Poland, Warsaw; France, Paris; Germany, Frankfurt; Spain, Madrid; UK, Reading
Onsite
Clinical Development
Spain, Madrid; Spain, Barcelona
Onsite
Clinical Development
Germany, Frankfurt
Onsite
Quality Assurance Methods
US, Nashville, TN
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
Poland Warsaw
Onsite
Clinical Development
Canada, Montreal; Toronto; Quebec City; New Brunswick; Quebec; British Columbia; Canada, Burlington; Vancouver
Onsite
Clinical Development
Chicago, IL
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Canada, Montreal
Onsite
Clinical Development
Greece, Athens
Onsite
Clinical Development
China, Beijing
Onsite
Clinical Development
Canada, Montreal; Toronto; New Brunswick; British Columbia; Quebec; Vancouver; Canada, Burlington
Onsite
Clinical Development
United States of America; US, Houston, TX; US, Lawrence, KS; US, Salt Lake City (PRA); US, Sherman Oaks, CA; US, Portland, OR; US, San Antonio, TX 78232
Onsite
Clinical Development
Kenya
Onsite
Clinical Development
Philippines, Manila
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Singapore, Singapore
Onsite
Clinical Development
US, Lenexa KCI (PRA)
Onsite
Clinical Development
Nashville TN
Onsite
Clinical Development
Spain, Madrid
Onsite
Clinical Development
Vietnam, Ho Chi Minh City
Onsite
Clinical Development
Canada
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Germany, Frankfurt; Germany, Mannheim
Onsite
Clinical Development
Regional Great Britain (Northern Ireland); Ireland, Dublin
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
India, Bangalore; India, Trivandrum; India, Chennai
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
US, Raleigh, NC
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
China, Shanghai
Onsite
Clinical Development
Poland, Warsaw; Poznan
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
Germany, Mannheim; Spain, Madrid
Onsite
Clinical Development
Australia, Melbourne; Australia, Adelaide
Onsite
Clinical Development
India, Bangalore
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Colombia, Bogota
Onsite
Clinical Development
US, Blue Bell (ICON); Rhode Island; New Jersey; Pennsylvania; Massachusetts; Connecticut
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
US, Farmingdale, NY
Onsite
Clinical Development
Canada, Burlington; Canada, Montreal
Onsite
Clinical Development
Argentina, Buenos Aires
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
UK, Reading
Onsite
Clinical Development
Colombia, Bogota; Chile, Santiago
Onsite
Clinical Development
Brazil, Sao Paulo
Onsite
Clinical Development
Bulgaria, Sofia; Poland, Warsaw; Poland, Gdansk
Onsite
Clinical Development
China Shanghai
Onsite
Project Management
Japan Tokyo
Onsite
Project Management
Bulgaria Sofia
Onsite
Project Management
Korea, Seoul
Onsite
Medical Regulatory Affairs
Belgium Mechelen
Onsite
Medical Regulatory Affairs
UK Reading
Onsite
Project Management
US Blue Bell ICON
Onsite
Project Management
Poland Gdansk
Onsite
Project Management
Colombia, Bogota
Onsite
Medical Regulatory Affairs
US Blue Bell ICON
Onsite
Project Management
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Ireland, Dublin
Onsite
Finance
Ireland, Dublin
Onsite
Finance
UK Reading
Onsite
Finance
Netherlands, Utrecht, Zen
Onsite
Finance
US Blue Bell ICON
Onsite
Quality Assurance Methods
UK, Reading
Onsite
Medical Affairs
US Blue Bell ICON
Onsite
Quality Assurance Methods
United States of America
Onsite
Quality Assurance Methods
Regional Great Britain (Northern Ireland)
Onsite
Quality Assurance Methods
Japan Tokyo
Onsite
Facilities & Administratives Services
Singapore, Singapore (Labs)
Onsite
Clinical Development
UK, Reading; Ireland, Dublin
Onsite
Clinical Development
UK Livingston
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development
United States of America
Onsite
Project Management
Japan, Tokyo; Japan, Osaka
Onsite
Clinical Development
Spain Madrid
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Philippines, Manila
Onsite
Clinical Development
China Beijing
Onsite
Clinical Development
Philadelphia, PA; Basking Ridge, NJ
Onsite
Clinical Development
Poland, Warsaw
Onsite
Clinical Development
Mexico, Mexico City
Onsite
Clinical Development
Israel, Tel Aviv
Onsite
Clinical Development
US, Blue Bell (ICON)
Onsite
Clinical Development
Taiwan, Taipei
Onsite
Clinical Development
Bulgaria, Sofia
Onsite
Medical Regulatory Affairs
Kenya
Onsite
Clinical Development
United States of America
Onsite
Clinical Development
Hungary, Budapest BUD2
Onsite
Clinical Development
Wisconsin
Onsite
Clinical Development
Turkey, Ankara
Onsite
Clinical Development
Belgium, Mechelen
Onsite
Clinical Development
Poland, Warsaw
Onsite
Medical Regulatory Affairs
Germany, Mannheim
Onsite
Clinical Development
Thailand, Bangkok
Onsite
Clinical Development
Korea, Seoul
Onsite
Clinical Development
Poland Warsaw
Onsite
Medical Regulatory Affairs
Netherlands, Groningen GRQM
Onsite
Medical Regulatory Affairs
Poland Warsaw
Onsite
Medical Regulatory Affairs
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
India, Chennai
Onsite
Medical Regulatory Affairs
China, Shanghai
Onsite
Medical Regulatory Affairs
India, Bangalore; India, Chennai
Onsite
Clinical Development
Portugal Lisbon
Onsite
Project Management
Germany, Frankfurt
Onsite
Business Development
Mexico, Mexico City
Onsite
Business Development
US, Blue Bell (ICON)
Onsite
Medical Affairs
UK Livingston
Onsite
Human Resources
UK Reading
Onsite
Human Resources
Spain Madrid
Onsite
Legal
US, Blue Bell (ICON); Regional Great Britain (Northern Ireland)
Onsite
Clinical Development
Armenia (Subcontract & Contractor only)
Onsite
Medical Regulatory Affairs
Belgium Mechelen
Onsite
Project Management
Mexico, Mexico City
Onsite
Project Management
Mexico, Mexico City
Onsite
IT
Poland Warsaw
Onsite
Project Management
Poland, Warsaw
Onsite
Finance
Mexico Mexico City
Onsite
Quality Assurance Methods
Bulgaria Sofia
Onsite
Human Resources
Colombia, Bogota; Mexico, Mexico City
Onsite
Clinical Development
Mexico Mexico City
Onsite
Quality Assurance Methods
Mexico, Mexico City
Onsite
Medical Regulatory Affairs
Greece, Athens
Onsite
Clinical Development
US Cambridge MA
Onsite
Project Management
Mexico, Mexico City
Onsite
Clinical Development
France, Paris
Onsite
Clinical Development